March 2011

Procter & Gamble is the innovation leader in our industry. Virtually all the organic sales growth we’ve delivered in the past nine years has come from new brands and new or improved product innovation. We continually strengthen our innovation capability and pipeline by investing two times more, on average, than our major competitors.

Guru Nanak Dev University was established at Amritsar on November 24, 1969 to mark the 500th birth anniversary of Sri Guru Nanak Dev Ji. It is both a residential and an affiliating university. In conceiving the future course of the University, the objectives enshrined in the Guru Nanak Dev University Act 1969, emphasised that the new University would make provision for imparting education and promoting research in the humanities, learned professions, sciences, especially of applied nature and technology.

Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 30,000 employees in 76 countries, and markets its products in 179 countries.
Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).

Surya Healthcare is a subsidiary of Surya Pharmaceuticals Limited with widespread domestic and international operations. The force behind Surya Healthcare is its parent company Surya Pharmaceuticals Limited. It is uniquely positioned in the Pharmaceutical trade known for its competencies in API, formulation and contract manufacturing across different therapeutic segments serving both domestic and international clients.